Acetazolamide
- Strength
- 125 mg/1
- Form
- Tablet
- Class
- Carbonic Anhydrase Inhibitor
PD-Rx Pharmaceuticals, Inc.
acetazolamide sodium
Listed by Mylan Institutional LLC
| Dosage form | Injection, Powder, Lyophilized, For Solution |
|---|---|
| Route | Intravenous |
| Drug class | Carbonic Anhydrase Inhibitor |
| Approval route | ANDA — approved generic |
| NDC code | 67457-853 |
| FDA application | ANDA200880 |
| RxNorm concept | 307702 |
| Package sizes listed | 1 |
| Marketed since | September 2018 |
Same active ingredient, different manufacturer, strength or form. Products matching on both ingredient and strength are usually interchangeable — but confirm before switching, especially with modified-release forms.
PD-Rx Pharmaceuticals, Inc.
PD-Rx Pharmaceuticals, Inc.
Aarkish Pharmaceuticals NJ Inc.
Marlex Pharmaceuticals, Inc.
AvPAK
Gland Pharma Limited
Zydus Pharmaceuticals (USA) Inc.
Zydus Pharmaceuticals (USA) Inc.
Information only, not medical advice. Nothing on this page indicates that a medication is safe or suitable for you. Speak to a prescriber or pharmacist before starting, stopping or switching any medicine.
Please don't share card details in chat.